UPDATE : Monday, April 22, 2019
[Special] Interleukin inhibitors Cosentyx, Taltz target psoriasis market
Interleukin inhibitors are rising as the newest psoriasis treatment.Tumor n...
by Kim Yun-mi  |  2019-03-26 14:56
Half of doctors suffer from traumatic experience as trainee
One out of two physicians in Korea suffered from traumatic experiences when...
by Song Soo-youn  |  2019-03-26 12:28
Philippines to start using VUNO’s AI solution
VUNO said Monday that it has signed a memorandum of understanding with medi...
by Lee Han-soo  |  2019-03-25 18:02
SNUH uses robot to increase success rate of sleep apnea surgery
Researchers at Seoul National University Hospital (SNUH) have found that ro...
by Lee Han-soo  |  2019-03-25 16:10
Doctors outrageous over MSD Korea’s recordings of their talks
Korean doctors are enraged, criticizing MSD Korea’s alleged collection of f...
by Park Gi-taek  |  2019-03-25 16:05
Celltrion licenses out hypertrophic cardiomyopathy treatment to Japan
Celltrion said Monday that it has signed an exclusive sales agreement with ...
by Lee Han-soo  |  2019-03-25 15:41
[Interview with global pharmas] ‘GSK Korea goes all out to help Korean patients, host nation's healthcare system’
A year has passed since Julien Samson took office as the head of GSK Korea ...
by Lee Han-soo  |  2019-03-25 15:15
TB patients went down 6.4% in Korea last year
The number of Koreans newly infected with tuberculosis decreased by 6.4 per...
by Kwak Sung-sun  |  2019-03-25 15:06
Daewoong releases P3 trial results for Nabota
Daewoong Pharmaceutical said Monday that it has published the U.S. phase 3 ...
by Lee Han-soo  |  2019-03-25 15:01
Doctors protest police raid amid Hotel Shilla CEO’s alleged propofol abuse
The medical community has expressed an outcry over the police’s recent raid...
by Choi Gwang-seok  |  2019-03-25 11:59
Regulator OKs immunotherapies developed by multinational pharma companies
The Ministry of Food and Drug Safety (MFDS) approved Bavenico, a monoclonal...
by Lee Han-soo  |  2019-03-25 11:28
[Reporter’s Notebook]‘What are you fighting for?’
Most lawmakers, who attend events organized by occupational associations to...
by Song Soo-youn  |  2019-03-25 11:25
Gore wins over Seoul after halting supply of artificial blood vessels
Gore Medical has secured a significant increase in the insurance cap for it...
by Kwak Sung-sun  |  2019-03-22 17:44
Otsuka Korea CEO receives presidential citation
Otsuka Korea said Friday that Moon Sung-ho, the company’s CEO, received a p...
by Lee Han-soo  |  2019-03-22 16:52
HIRA puts brakes on Gilead’s AIDS treatment receiving reimbursement.
The reimbursement plan for Gilead Science Korea’s Biktarvy, an acquired imm...
by Song Soo-youn  |  2019-03-22 15:50
Setback in search for Alzheimer’s drug: Biogen halts phase-3 aducanumab trials
Biogen announced on Thursday that it would discontinue the phase-3 trials o...
by Kim Yun-mi  |  2019-03-22 15:50
Eubiologics gets nod to test botulinum toxin in phase-1 study
Eubiologics said it has begun developing a botulinum toxin product.The Mini...
by Lee Hye-seon  |  2019-03-22 15:28
Regulator OKs Medipost’s P1 trial of knee osteoarthritis treatment
Medipost said Thursday that the Ministry of Food and Drug Safety has approv...
by Lee Han-soo  |  2019-03-22 14:22
Samsung Bioepis unveils 3-year follow-up data for Ontruzant
Samsung Bioepis said Friday that it has presented the three-year follow-up ...
by Lee Han-soo  |  2019-03-22 14:05
‘MSD Korea excessively monitors workers, collects client info without consent’
MSD Korea used to be called one of the best workplaces in the pharmaceutica...
by Jeong Sae-im  |  2019-03-22 13:49
Back to Top